nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Mefloquine—HBA1—sarcoma	0.0819	1	CrCbGaD
Flecainide—Malaise—Etoposide—sarcoma	0.00182	0.00199	CcSEcCtD
Flecainide—Vertigo—Etoposide—sarcoma	0.00182	0.00198	CcSEcCtD
Flecainide—Abdominal pain—Thiotepa—sarcoma	0.00182	0.00198	CcSEcCtD
Flecainide—Body temperature increased—Thiotepa—sarcoma	0.00182	0.00198	CcSEcCtD
Flecainide—Leukopenia—Etoposide—sarcoma	0.00181	0.00197	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00181	0.00197	CcSEcCtD
Flecainide—Body temperature increased—Dactinomycin—sarcoma	0.0018	0.00196	CcSEcCtD
Flecainide—Abdominal pain—Dactinomycin—sarcoma	0.0018	0.00196	CcSEcCtD
Flecainide—Cardiac arrest—Epirubicin—sarcoma	0.00179	0.00195	CcSEcCtD
Flecainide—Paraesthesia—Mitoxantrone—sarcoma	0.00178	0.00194	CcSEcCtD
Flecainide—Loss of consciousness—Etoposide—sarcoma	0.00178	0.00194	CcSEcCtD
Flecainide—Decreased appetite—Vincristine—sarcoma	0.00177	0.00193	CcSEcCtD
Flecainide—Ataxia—Epirubicin—sarcoma	0.00177	0.00193	CcSEcCtD
Flecainide—Dyspnoea—Mitoxantrone—sarcoma	0.00177	0.00193	CcSEcCtD
Flecainide—Cough—Etoposide—sarcoma	0.00177	0.00192	CcSEcCtD
Flecainide—Somnolence—Mitoxantrone—sarcoma	0.00177	0.00192	CcSEcCtD
Flecainide—Gastrointestinal disorder—Vincristine—sarcoma	0.00176	0.00192	CcSEcCtD
Flecainide—Fatigue—Vincristine—sarcoma	0.00176	0.00191	CcSEcCtD
Flecainide—Convulsion—Etoposide—sarcoma	0.00175	0.00191	CcSEcCtD
Flecainide—Dyspepsia—Mitoxantrone—sarcoma	0.00175	0.0019	CcSEcCtD
Flecainide—Hypertension—Etoposide—sarcoma	0.00175	0.0019	CcSEcCtD
Flecainide—Pain—Vincristine—sarcoma	0.00174	0.0019	CcSEcCtD
Flecainide—Constipation—Vincristine—sarcoma	0.00174	0.0019	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00174	0.0019	CcSEcCtD
Flecainide—Diplopia—Doxorubicin—sarcoma	0.00174	0.0019	CcSEcCtD
Flecainide—Decreased appetite—Mitoxantrone—sarcoma	0.00173	0.00188	CcSEcCtD
Flecainide—Chest pain—Etoposide—sarcoma	0.00172	0.00188	CcSEcCtD
Flecainide—Fatigue—Mitoxantrone—sarcoma	0.00171	0.00186	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00171	0.00186	CcSEcCtD
Flecainide—Discomfort—Etoposide—sarcoma	0.0017	0.00185	CcSEcCtD
Flecainide—Pain—Mitoxantrone—sarcoma	0.0017	0.00185	CcSEcCtD
Flecainide—Constipation—Mitoxantrone—sarcoma	0.0017	0.00185	CcSEcCtD
Flecainide—Gastrointestinal pain—Vincristine—sarcoma	0.00167	0.00182	CcSEcCtD
Flecainide—Confusional state—Etoposide—sarcoma	0.00167	0.00181	CcSEcCtD
Flecainide—Cardiac arrest—Doxorubicin—sarcoma	0.00166	0.00181	CcSEcCtD
Flecainide—Asthenia—Thiotepa—sarcoma	0.00165	0.0018	CcSEcCtD
Flecainide—Ataxia—Doxorubicin—sarcoma	0.00164	0.00178	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—sarcoma	0.00164	0.00178	CcSEcCtD
Flecainide—Feeling abnormal—Mitoxantrone—sarcoma	0.00164	0.00178	CcSEcCtD
Flecainide—Pruritus—Thiotepa—sarcoma	0.00163	0.00177	CcSEcCtD
Flecainide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00162	0.00177	CcSEcCtD
Flecainide—Thrombocytopenia—Etoposide—sarcoma	0.00162	0.00176	CcSEcCtD
Flecainide—Tachycardia—Etoposide—sarcoma	0.00161	0.00176	CcSEcCtD
Flecainide—Abdominal pain—Vincristine—sarcoma	0.00161	0.00176	CcSEcCtD
Flecainide—Body temperature increased—Vincristine—sarcoma	0.00161	0.00176	CcSEcCtD
Flecainide—Skin disorder—Etoposide—sarcoma	0.0016	0.00175	CcSEcCtD
Flecainide—Hyperhidrosis—Etoposide—sarcoma	0.0016	0.00174	CcSEcCtD
Flecainide—Angina pectoris—Epirubicin—sarcoma	0.00159	0.00173	CcSEcCtD
Flecainide—Urticaria—Mitoxantrone—sarcoma	0.00158	0.00172	CcSEcCtD
Flecainide—Anorexia—Etoposide—sarcoma	0.00157	0.00171	CcSEcCtD
Flecainide—Diarrhoea—Thiotepa—sarcoma	0.00157	0.00171	CcSEcCtD
Flecainide—Body temperature increased—Mitoxantrone—sarcoma	0.00157	0.00171	CcSEcCtD
Flecainide—Abdominal pain—Mitoxantrone—sarcoma	0.00157	0.00171	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—sarcoma	0.00156	0.0017	CcSEcCtD
Flecainide—Hypotension—Etoposide—sarcoma	0.00154	0.00168	CcSEcCtD
Flecainide—Dysuria—Epirubicin—sarcoma	0.00152	0.00166	CcSEcCtD
Flecainide—Dizziness—Thiotepa—sarcoma	0.00152	0.00166	CcSEcCtD
Flecainide—Photosensitivity reaction—Epirubicin—sarcoma	0.00149	0.00162	CcSEcCtD
Flecainide—Paraesthesia—Etoposide—sarcoma	0.00148	0.00162	CcSEcCtD
Flecainide—Dyspnoea—Etoposide—sarcoma	0.00147	0.0016	CcSEcCtD
Flecainide—Hyperglycaemia—Epirubicin—sarcoma	0.00147	0.0016	CcSEcCtD
Flecainide—Somnolence—Etoposide—sarcoma	0.00147	0.0016	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—sarcoma	0.00147	0.0016	CcSEcCtD
Flecainide—Asthenia—Vincristine—sarcoma	0.00146	0.00159	CcSEcCtD
Flecainide—Vomiting—Thiotepa—sarcoma	0.00146	0.00159	CcSEcCtD
Flecainide—Pneumonia—Epirubicin—sarcoma	0.00146	0.00159	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—sarcoma	0.00145	0.00158	CcSEcCtD
Flecainide—Rash—Thiotepa—sarcoma	0.00145	0.00158	CcSEcCtD
Flecainide—Dermatitis—Thiotepa—sarcoma	0.00145	0.00158	CcSEcCtD
Flecainide—Headache—Thiotepa—sarcoma	0.00144	0.00157	CcSEcCtD
Flecainide—Rash—Dactinomycin—sarcoma	0.00144	0.00157	CcSEcCtD
Flecainide—Decreased appetite—Etoposide—sarcoma	0.00144	0.00156	CcSEcCtD
Flecainide—Renal failure—Epirubicin—sarcoma	0.00143	0.00155	CcSEcCtD
Flecainide—Gastrointestinal disorder—Etoposide—sarcoma	0.00143	0.00155	CcSEcCtD
Flecainide—Asthenia—Mitoxantrone—sarcoma	0.00142	0.00155	CcSEcCtD
Flecainide—Fatigue—Etoposide—sarcoma	0.00142	0.00155	CcSEcCtD
Flecainide—Neuropathy peripheral—Epirubicin—sarcoma	0.00142	0.00155	CcSEcCtD
Flecainide—Jaundice—Epirubicin—sarcoma	0.00141	0.00154	CcSEcCtD
Flecainide—Constipation—Etoposide—sarcoma	0.00141	0.00154	CcSEcCtD
Flecainide—Pain—Etoposide—sarcoma	0.00141	0.00154	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—sarcoma	0.00141	0.00153	CcSEcCtD
Flecainide—Diarrhoea—Vincristine—sarcoma	0.00139	0.00152	CcSEcCtD
Flecainide—Haematuria—Epirubicin—sarcoma	0.00138	0.00151	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—sarcoma	0.00137	0.0015	CcSEcCtD
Flecainide—Nausea—Thiotepa—sarcoma	0.00137	0.00149	CcSEcCtD
Flecainide—Feeling abnormal—Etoposide—sarcoma	0.00136	0.00148	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—sarcoma	0.00136	0.00148	CcSEcCtD
Flecainide—Diarrhoea—Mitoxantrone—sarcoma	0.00136	0.00148	CcSEcCtD
Flecainide—Nausea—Dactinomycin—sarcoma	0.00136	0.00148	CcSEcCtD
Flecainide—Agranulocytosis—Epirubicin—sarcoma	0.00135	0.00148	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—sarcoma	0.00135	0.00147	CcSEcCtD
Flecainide—Gastrointestinal pain—Etoposide—sarcoma	0.00135	0.00147	CcSEcCtD
Flecainide—Dizziness—Vincristine—sarcoma	0.00135	0.00147	CcSEcCtD
Flecainide—Bradycardia—Epirubicin—sarcoma	0.00133	0.00144	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—sarcoma	0.00132	0.00144	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—sarcoma	0.00132	0.00143	CcSEcCtD
Flecainide—Urticaria—Etoposide—sarcoma	0.00131	0.00143	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—sarcoma	0.00131	0.00143	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—sarcoma	0.00131	0.00142	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—sarcoma	0.00131	0.00142	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—sarcoma	0.0013	0.00141	CcSEcCtD
Flecainide—Vomiting—Vincristine—sarcoma	0.0013	0.00141	CcSEcCtD
Flecainide—Rash—Vincristine—sarcoma	0.00129	0.0014	CcSEcCtD
Flecainide—Dermatitis—Vincristine—sarcoma	0.00128	0.0014	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—sarcoma	0.00128	0.00139	CcSEcCtD
Flecainide—Headache—Vincristine—sarcoma	0.00128	0.00139	CcSEcCtD
Flecainide—Vomiting—Mitoxantrone—sarcoma	0.00126	0.00138	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—sarcoma	0.00126	0.00137	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—sarcoma	0.00125	0.00137	CcSEcCtD
Flecainide—Rash—Mitoxantrone—sarcoma	0.00125	0.00136	CcSEcCtD
Flecainide—Dermatitis—Mitoxantrone—sarcoma	0.00125	0.00136	CcSEcCtD
Flecainide—Headache—Mitoxantrone—sarcoma	0.00124	0.00135	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—sarcoma	0.00123	0.00134	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—sarcoma	0.00122	0.00133	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—sarcoma	0.00121	0.00132	CcSEcCtD
Flecainide—Nausea—Vincristine—sarcoma	0.00121	0.00132	CcSEcCtD
Flecainide—Flushing—Epirubicin—sarcoma	0.00121	0.00132	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—sarcoma	0.0012	0.00131	CcSEcCtD
Flecainide—Asthenia—Etoposide—sarcoma	0.00118	0.00129	CcSEcCtD
Flecainide—Nausea—Mitoxantrone—sarcoma	0.00118	0.00128	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—sarcoma	0.00118	0.00128	CcSEcCtD
Flecainide—Pruritus—Etoposide—sarcoma	0.00117	0.00127	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—sarcoma	0.00116	0.00127	CcSEcCtD
Flecainide—Alopecia—Epirubicin—sarcoma	0.00115	0.00125	CcSEcCtD
Flecainide—Diarrhoea—Etoposide—sarcoma	0.00113	0.00123	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—sarcoma	0.00113	0.00123	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—sarcoma	0.00112	0.00122	CcSEcCtD
Flecainide—Flushing—Doxorubicin—sarcoma	0.00112	0.00122	CcSEcCtD
Flecainide—Flatulence—Epirubicin—sarcoma	0.00112	0.00122	CcSEcCtD
Flecainide—Tension—Epirubicin—sarcoma	0.00111	0.00121	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—sarcoma	0.00111	0.00121	CcSEcCtD
Flecainide—Nervousness—Epirubicin—sarcoma	0.0011	0.0012	CcSEcCtD
Flecainide—Dizziness—Etoposide—sarcoma	0.00109	0.00119	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—sarcoma	0.00109	0.00119	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—sarcoma	0.00107	0.00116	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—sarcoma	0.00107	0.00116	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—sarcoma	0.00105	0.00115	CcSEcCtD
Flecainide—Vomiting—Etoposide—sarcoma	0.00105	0.00114	CcSEcCtD
Flecainide—Rash—Etoposide—sarcoma	0.00104	0.00113	CcSEcCtD
Flecainide—Dermatitis—Etoposide—sarcoma	0.00104	0.00113	CcSEcCtD
Flecainide—Headache—Etoposide—sarcoma	0.00103	0.00113	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—sarcoma	0.00103	0.00113	CcSEcCtD
Flecainide—Tension—Doxorubicin—sarcoma	0.00103	0.00112	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—sarcoma	0.00103	0.00112	CcSEcCtD
Flecainide—Malaise—Epirubicin—sarcoma	0.00102	0.00111	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—sarcoma	0.00102	0.00111	CcSEcCtD
Flecainide—Vertigo—Epirubicin—sarcoma	0.00102	0.00111	CcSEcCtD
Flecainide—Syncope—Epirubicin—sarcoma	0.00102	0.00111	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—sarcoma	0.00102	0.00111	CcSEcCtD
Flecainide—Palpitations—Epirubicin—sarcoma	0.001	0.00109	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—sarcoma	0.000997	0.00109	CcSEcCtD
Flecainide—Cough—Epirubicin—sarcoma	0.00099	0.00108	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—sarcoma	0.000989	0.00108	CcSEcCtD
Flecainide—Convulsion—Epirubicin—sarcoma	0.000983	0.00107	CcSEcCtD
Flecainide—Nausea—Etoposide—sarcoma	0.000981	0.00107	CcSEcCtD
Flecainide—Hypertension—Epirubicin—sarcoma	0.000979	0.00107	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—sarcoma	0.000974	0.00106	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—sarcoma	0.000966	0.00105	CcSEcCtD
Flecainide—Chest pain—Epirubicin—sarcoma	0.000966	0.00105	CcSEcCtD
Flecainide—Myalgia—Epirubicin—sarcoma	0.000966	0.00105	CcSEcCtD
Flecainide—Anxiety—Epirubicin—sarcoma	0.000962	0.00105	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000959	0.00104	CcSEcCtD
Flecainide—Discomfort—Epirubicin—sarcoma	0.000954	0.00104	CcSEcCtD
Flecainide—Malaise—Doxorubicin—sarcoma	0.000947	0.00103	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—sarcoma	0.000944	0.00103	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—sarcoma	0.000943	0.00103	CcSEcCtD
Flecainide—Syncope—Doxorubicin—sarcoma	0.000941	0.00103	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—sarcoma	0.00094	0.00102	CcSEcCtD
Flecainide—Confusional state—Epirubicin—sarcoma	0.000933	0.00102	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—sarcoma	0.000928	0.00101	CcSEcCtD
Flecainide—Oedema—Epirubicin—sarcoma	0.000926	0.00101	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—sarcoma	0.000922	0.001	CcSEcCtD
Flecainide—Cough—Doxorubicin—sarcoma	0.000916	0.000998	CcSEcCtD
Flecainide—Shock—Epirubicin—sarcoma	0.000911	0.000992	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—sarcoma	0.000909	0.000991	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—sarcoma	0.000908	0.000989	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—sarcoma	0.000906	0.000987	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—sarcoma	0.000906	0.000987	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—sarcoma	0.000904	0.000984	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—sarcoma	0.000899	0.000979	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—sarcoma	0.000895	0.000975	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—sarcoma	0.000894	0.000973	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—sarcoma	0.000894	0.000973	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—sarcoma	0.000894	0.000973	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—sarcoma	0.00089	0.00097	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000887	0.000967	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—sarcoma	0.000883	0.000962	CcSEcCtD
Flecainide—Anorexia—Epirubicin—sarcoma	0.000882	0.000961	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—sarcoma	0.000874	0.000952	CcSEcCtD
Flecainide—Hypotension—Epirubicin—sarcoma	0.000865	0.000942	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—sarcoma	0.000864	0.000941	CcSEcCtD
Flecainide—Oedema—Doxorubicin—sarcoma	0.000857	0.000933	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000843	0.000919	CcSEcCtD
Flecainide—Shock—Doxorubicin—sarcoma	0.000843	0.000918	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—sarcoma	0.00084	0.000915	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—sarcoma	0.000839	0.000914	CcSEcCtD
Flecainide—Insomnia—Epirubicin—sarcoma	0.000837	0.000912	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—sarcoma	0.000836	0.000911	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—sarcoma	0.000832	0.000906	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—sarcoma	0.000831	0.000905	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—sarcoma	0.000828	0.000902	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—sarcoma	0.000825	0.000899	CcSEcCtD
Flecainide—Somnolence—Epirubicin—sarcoma	0.000823	0.000896	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—sarcoma	0.000817	0.000889	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—sarcoma	0.000815	0.000888	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—sarcoma	0.000805	0.000877	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—sarcoma	0.0008	0.000872	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000799	0.000871	CcSEcCtD
Flecainide—Fatigue—Epirubicin—sarcoma	0.000798	0.000869	CcSEcCtD
Flecainide—Pain—Epirubicin—sarcoma	0.000792	0.000862	CcSEcCtD
Flecainide—Constipation—Epirubicin—sarcoma	0.000792	0.000862	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00078	0.00085	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—sarcoma	0.000775	0.000844	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—sarcoma	0.000769	0.000838	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—sarcoma	0.000764	0.000832	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—sarcoma	0.000763	0.000831	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—sarcoma	0.000762	0.000829	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—sarcoma	0.000757	0.000825	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—sarcoma	0.000754	0.000821	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—sarcoma	0.000745	0.000811	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00074	0.000806	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—sarcoma	0.000739	0.000804	CcSEcCtD
Flecainide—Urticaria—Epirubicin—sarcoma	0.000735	0.000801	CcSEcCtD
Flecainide—Pain—Doxorubicin—sarcoma	0.000733	0.000798	CcSEcCtD
Flecainide—Constipation—Doxorubicin—sarcoma	0.000733	0.000798	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—sarcoma	0.000732	0.000797	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—sarcoma	0.000732	0.000797	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—sarcoma	0.000706	0.000769	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—sarcoma	0.0007	0.000763	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—sarcoma	0.00068	0.000741	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—sarcoma	0.000677	0.000738	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—sarcoma	0.000677	0.000738	CcSEcCtD
Flecainide—Asthenia—Epirubicin—sarcoma	0.000664	0.000723	CcSEcCtD
Flecainide—Pruritus—Epirubicin—sarcoma	0.000655	0.000713	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—sarcoma	0.000633	0.00069	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—sarcoma	0.000615	0.000669	CcSEcCtD
Flecainide—Dizziness—Epirubicin—sarcoma	0.000612	0.000667	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—sarcoma	0.000606	0.00066	CcSEcCtD
Flecainide—Vomiting—Epirubicin—sarcoma	0.000589	0.000641	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—sarcoma	0.000586	0.000638	CcSEcCtD
Flecainide—Rash—Epirubicin—sarcoma	0.000584	0.000636	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—sarcoma	0.000583	0.000635	CcSEcCtD
Flecainide—Headache—Epirubicin—sarcoma	0.00058	0.000632	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—sarcoma	0.000566	0.000617	CcSEcCtD
Flecainide—Nausea—Epirubicin—sarcoma	0.00055	0.000599	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—sarcoma	0.000545	0.000593	CcSEcCtD
Flecainide—Rash—Doxorubicin—sarcoma	0.00054	0.000588	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—sarcoma	0.00054	0.000588	CcSEcCtD
Flecainide—Headache—Doxorubicin—sarcoma	0.000537	0.000585	CcSEcCtD
Flecainide—Nausea—Doxorubicin—sarcoma	0.000509	0.000554	CcSEcCtD
